LOC497661 Inhibitors
C18orf32, which stands for "chromosome 18 open reading frame 32," is a protein encoded by the gene located on the 18th chromosome in a region designated as an open reading frame (ORF). As the name suggests, this protein is identified by its genetic location rather than a known function or characteristic structural domain. Proteins named in this manner are often those about which relatively little is known, and they tend to be subjects of ongoing research to elucidate their biological roles.C18orf32 may involve bioinformatics analyses to predict its structure and function based on sequence homology, as well as experimental approaches such as gene knockout studies, protein expression profiling, and interaction studies to understand its role in the cell. These studies might reveal involvement in signaling pathways, regulatory networks, or cellular structures.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum kinase inhibitor, which may affect multiple signaling pathways potentially connected to C18orf32. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, which might impact protein synthesis and cell growth pathways, potentially influencing C18orf32 function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor, which could affect protein degradation pathways, potentially relevant to C18orf32. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, which could impact signaling pathways that might intersect with C18orf32-related processes. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
An antimetabolite that inhibits thymidylate synthase, potentially affecting DNA synthesis and repair mechanisms connected to C18orf32. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
An immunosuppressant that inhibits calcineurin, potentially impacting signaling pathways relevant to C18orf32. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
A SERCA pump inhibitor, affecting calcium homeostasis, which might influence C18orf32-related processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An inhibitor of MAP kinase kinase (MEK), potentially affecting signaling pathways related to C18orf32. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor, affecting cytoskeletal dynamics, which might be relevant to C18orf32. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $74.00 | 256 | |
A pan-caspase inhibitor, potentially influencing apoptotic pathways indirectly related to C18orf32. | ||||||